通过激活PI3K/Akt/NF-κB信号通路,AFP促进癌症的多药性耐药性
Siren Feng1, Chao Zhang1,2, Yi Chen1
1Key Laboratory of Tropical Translational Medicine, Ministry of Education, and Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical University, 3 Xueyuan Road, Haikou, 571199, People's Republic of China.
Scientific reports
|November 29, 2025
概括
阿尔法-胎蛋白 (AFP) 通过激活PI3K/Akt/NF-κB通路,促进癌症药物耐药性. 沉默AFP会增加对化学疗法药物的敏感性,例如多克索鲁比辛和5-甲.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿尔法-胎蛋白 (AFP) 与肝癌中的恶性行为有关.
- 癌症多药耐药性 (MDR) 中AFP的作用及其潜在机制在很大程度上是未知的.
研究的目的:
- 为了研究AFP对癌细胞多药耐药性的影响.
- 阐明AFP调节耐药性的分子机制,重点关注PI3K/Akt/NF-κB信号通路.
主要方法:
- 利用RNA干扰使Bel 7402细胞中的AFP沉默,以及HeLa细胞中的AFP过度表达.
- 通过MTT测定,通过TUNEL测定和殖民地形成测定来评估药物敏感性.
- 分析了药物耐药性标记物和信号通路组件 (例如,Akt,p65) 的蛋白质表达,使用西式斑点和免疫光学.
主要成果:
- 抑制AFP增强了Bel 7402细胞对多克索鲁比 (ADM) 和5-甲 (5-FU) 的敏感性.
- 在HeLa细胞中,AFP的过度表达赋予了对ADM和5-FU的耐药性.
- PI3K/Akt/NF-κB通路的AFP激活与耐药基因的表达相关.
结论:
- 在癌细胞中介于多药耐药性方面,AFP起着重要作用.
- 通过激活PI3K/Akt/NF-κB信号通路,AFP调节药物耐药性,从而影响关键耐药性相关基因的表达.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K


